Down Syndrome Screening at 30: Tests, Options & Information
At age 30, several screening and diagnostic tests for Down syndrome are available. Choice depends on individual factors (age, family history, preferences). Common tests:
Screening Tests
- Non-Invasive Prenatal Screening (NIPS): Cell-free DNA analysis from maternal blood; can be done from 10 weeks; estimates risk of chromosomal abnormalities.
- First-Trimester Combined Screening: Maternal age, blood tests (PAPP-A, hCG), and nuchal translucency ultrasound; 11–14 weeks.
- Second-Trimester Quadruple Screen: Measures AFP, hCG, estriol, inhibin-A; 15–20 weeks.
Diagnostic Tests
- Chorionic Villus Sampling (CVS): Placental tissue sample; 10+ weeks; slightly higher complication risk than amniocentesis.
- Amniocentesis: Amniotic fluid sample; 15–20 weeks; analyzes fetal cells for chromosomal abnormalities.
Discuss benefits, limitations, and risks with your provider to make an informed decision.
Pregnancy & Health - Related Articles
- Medical Abortion Statistics in the US: Trends, Definitions, and Data Sources
- Snoring During Pregnancy: Causes, Concerns, and Solutions
- Pregnancy & Baby Health: The Impact of Smoking and Stress
- Natural Labor Induction Methods: Safe and Effective Options
- Miscarriage Risk: How It Changes During Pregnancy
- Navigating Early Pregnancy: Challenges and Successes
- Confirming Pregnancy: Methods and What to Expect
